PARX PLASTICS
Dutch antibacterial additives firm joins Euronext stock exchange
 The Dutch company's antimicrobial additives can be used in products such as plastic cutting boards (Photo: Parx Plastics) |
Antimicrobial plastics specialist Parx Plastics (Rotterdam / The Netherlands; www.parxplastics.com) has been listed on the Euronext Access Paris stock exchange. The listing, which was done by a private placing of 6.8m shares at EUR 3.57 a share, values the company at EUR 24.3m. The Euronext Access exchange is designed for small companies and start-ups who want to access capital but do not meet the criteria for admission onto one of Euronext’s more regulated markets.
Using biomimicry Parx Plastics has developed and patented an antimicrobial technology for exploiting trace elements in plastics. This creates a defence mechanism, reducing the amount of bacteria, moulds, fungi and biofilm on surfaces by at least 99% when tested according to international standard ISO 22196 for the measurement of antibacterial activity on plastics.
The firm said its technology distinguished itself from other solutions by not having to rely on the use of toxic substances such as triclosan, heavy metals quaternary ammonium salts or nanomaterials. And the technology does not depend on migration, as the antimicrobial technology is an inert part of the material, and able to improve the material’s mechanical properties, making it more resistant to microbes.
In February, Parx Plastics announced the launch of two specific grades of materials: "PE 0020 Saniconcentrate" LLDPE and "PP 0016 Saniconcentrate" PP random copolymer. Both materials were tested using an injection production process by an accredited independent laboratory according to ISO 22196 to measure the antibacterial activity on the surface of the samples. Parx Plastics said both materials also gave the highest result in the antibacterial efficacy tests for E. coli and for S. aureus bacteria.
The same month, the Dutch company revealed that its technology had been successfully tested more than 400 times by a number of international laboratories. These include the Guangdong Detection Center of Microbiology (Guangzhou, Guangdong / China; www.gddcm.com) and the Kaken Test Center (Tokyo / Japan; http://en.kaken.or.jp).
Using biomimicry Parx Plastics has developed and patented an antimicrobial technology for exploiting trace elements in plastics. This creates a defence mechanism, reducing the amount of bacteria, moulds, fungi and biofilm on surfaces by at least 99% when tested according to international standard ISO 22196 for the measurement of antibacterial activity on plastics.
The firm said its technology distinguished itself from other solutions by not having to rely on the use of toxic substances such as triclosan, heavy metals quaternary ammonium salts or nanomaterials. And the technology does not depend on migration, as the antimicrobial technology is an inert part of the material, and able to improve the material’s mechanical properties, making it more resistant to microbes.
In February, Parx Plastics announced the launch of two specific grades of materials: "PE 0020 Saniconcentrate" LLDPE and "PP 0016 Saniconcentrate" PP random copolymer. Both materials were tested using an injection production process by an accredited independent laboratory according to ISO 22196 to measure the antibacterial activity on the surface of the samples. Parx Plastics said both materials also gave the highest result in the antibacterial efficacy tests for E. coli and for S. aureus bacteria.
The same month, the Dutch company revealed that its technology had been successfully tested more than 400 times by a number of international laboratories. These include the Guangdong Detection Center of Microbiology (Guangzhou, Guangdong / China; www.gddcm.com) and the Kaken Test Center (Tokyo / Japan; http://en.kaken.or.jp).
08.05.2018 Plasteurope.com [239685-0]
Published on 08.05.2018